Skip to product information
1 of 1

B. Braun

B Braun Prontosan Debridement Pad

B Braun Prontosan Debridement Pad

Regular price $14.20 SGD
Regular price $0.00 SGD Sale price $14.20 SGD
Sale Sold out
Shipping calculated at checkout.
Quantity
Clinical Summary: The B. Braun Prontosan Debridement Pad is a Class I CE-marked medical device designed for soft mechanical debridement of chronic wounds. It utilises microfibre technology in a teardrop-shaped pad to gently remove slough, biofilm, debris, and dead cell residue from the wound bed and peri-wound skin. It is intended for use in combination with Prontosan Wound Irrigation Solution or Prontosan Wound Gel.

Product Overview

The Prontosan Debridement Pad addresses a critical step in wound bed preparation: the removal of non-viable tissue, slough, and wound coatings that impede healing. Unlike sharp debridement techniques, the Prontosan Debridement Pad provides a controlled, low-trauma approach using densely packed microfibre filaments. These microfibres mechanically lift and trap wound debris while the pad's absorbent outer layer contains exudate, reducing the risk of cross-contamination during the procedure.

The pad's innovative teardrop geometry features a broad rounded end for cleansing larger wound surfaces and a tapered pointed end for accessing wound undermining, tunnels, and irregular cavity margins. Each pad is individually blister-packed to maintain asepsis prior to use and is designed for single-patient, single-procedure application. The Prontosan Debridement Pad is used in hospitals, wound care clinics, and community nursing settings across Singapore and the Asia-Pacific region.

Specifications

Manufacturer B. Braun Melsungen AG, Germany
Product Name Prontosan Debridement Pad
Technology Microfibre mechanical debridement
Pad Shape Teardrop (rounded end + tapered end)
Mechanism Soft mechanical debridement via microfibre filaments
Compatibility Prontosan Wound Irrigation Solution / Prontosan Wound Gel
Sterility Individually blister-packed; single-use
Latex Content Latex-free
Device Classification Class I Medical Device (EU MDR 2017/745)
Regulatory CE Marked; ISO 13485 certified manufacturing; HSA Singapore notified
Packaging Options Single piece or Box of 10 pads

Clinical Indications

  • Pressure Ulcers (Stage II-IV): Removal of slough and non-viable tissue from pressure injuries as part of wound bed preparation per EPUAP/NPIAP/PPPIA guidelines
  • Venous Leg Ulcers: Debridement of fibrinous coatings and biofilm in venous stasis ulcers to promote granulation tissue formation
  • Diabetic Foot Ulcers: Gentle debridement of neuropathic ulcers where sharp debridement may be contraindicated or patient tolerance is limited
  • Surgical Wound Dehiscence: Cleansing of wound beds following wound breakdown to prepare for secondary closure or negative-pressure wound therapy
  • Biofilm Disruption: Mechanical disruption of bacterial biofilm in chronic wounds, supported by European Wound Management Association (EWMA) consensus recommendations on biofilm management

Frequently Asked Questions

How does the Prontosan Debridement Pad differ from gauze-based wound cleansing?

Standard gauze has a relatively coarse fibre structure that can traumatise fragile granulation tissue during wound cleansing. The Prontosan Debridement Pad uses engineered microfibre filaments that are significantly finer, enabling effective debris removal with reduced tissue trauma. Clinical evaluation data published in Wounds International demonstrates that the microfibre pad achieves more thorough slough removal compared to conventional gauze and cotton-based methods.

Should the pad be used wet or dry?

B. Braun recommends soaking the Debridement Pad in Prontosan Wound Irrigation Solution for approximately 1-2 minutes before use. The Prontosan solution (containing polyhexanide 0.1% and undecylenamidopropyl betaine 0.1%) works synergistically with the microfibre pad to loosen biofilm and debris, enhancing the mechanical debridement action. The pad may also be used with Prontosan Wound Gel for targeted application.

Is this pad suitable for use on acute wounds?

The Prontosan Debridement Pad is primarily indicated for chronic wound management. For acute surgical or traumatic wounds, consult the treating clinician regarding the appropriateness of mechanical debridement. In cases where an acute wound develops necrotic tissue or biofilm (e.g., delayed healing), the pad may be appropriate as determined by wound assessment protocols aligned with the Singapore Wound Healing Society guidelines.

How often should debridement with this pad be performed?

Debridement frequency depends on wound assessment findings, including the quantity and type of non-viable tissue present. The European Wound Management Association (EWMA) recommends reassessing the wound bed at each dressing change. Many clinicians incorporate debridement pad use at each scheduled dressing change (typically every 2-3 days) until a clean wound bed with viable granulation tissue is achieved.

Can the pad be reused on the same patient?

No. Each Prontosan Debridement Pad is a single-use device. Reuse may compromise device integrity, reduce debridement efficacy, and increase the risk of wound infection. Dispose of used pads in clinical waste per your facility's infection control and waste management protocols compliant with the Singapore Environmental Public Health Act.

View full details